MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 69 filers reported holding MEI PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $40,000 | -87.6% | 105,473 | -80.1% | 0.00% | – |
| Q2 2022 | $323,000 | -12.2% | 529,700 | -13.6% | 0.00% | – |
| Q1 2022 | $368,000 | -86.9% | 612,818 | -41.8% | 0.00% | – |
| Q4 2021 | $2,810,000 | +1277.5% | 1,052,368 | +1320.3% | 0.00% | – |
| Q3 2021 | $204,000 | -50.7% | 74,095 | -49.0% | 0.00% | – |
| Q2 2021 | $414,000 | -58.7% | 145,198 | -50.3% | 0.00% | – |
| Q1 2021 | $1,002,000 | -28.4% | 292,200 | -44.8% | 0.00% | – |
| Q4 2020 | $1,400,000 | +54.5% | 529,300 | +82.0% | 0.00% | – |
| Q3 2020 | $906,000 | +39.2% | 290,755 | +84.5% | 0.00% | – |
| Q2 2020 | $651,000 | +526.0% | 157,600 | +145.6% | 0.00% | – |
| Q1 2020 | $104,000 | +44.4% | 64,171 | +122.3% | 0.00% | – |
| Q4 2019 | $72,000 | -96.2% | 28,862 | -97.5% | 0.00% | – |
| Q3 2019 | $1,919,000 | -81.7% | 1,142,081 | -72.8% | 0.00% | -100.0% |
| Q2 2019 | $10,496,000 | +752.6% | 4,198,598 | +947.4% | 0.00% | – |
| Q1 2019 | $1,231,000 | +194.5% | 400,858 | +153.3% | 0.00% | – |
| Q4 2018 | $418,000 | -84.6% | 158,280 | -74.8% | 0.00% | -100.0% |
| Q3 2018 | $2,707,000 | +5.0% | 628,062 | -4.0% | 0.00% | 0.0% |
| Q2 2018 | $2,578,000 | +731.6% | 654,300 | +337.1% | 0.00% | – |
| Q1 2018 | $310,000 | +116.8% | 149,700 | +119.8% | 0.00% | – |
| Q4 2017 | $143,000 | -80.5% | 68,116 | -75.0% | 0.00% | – |
| Q3 2017 | $732,000 | +1491.3% | 272,800 | +1318.5% | 0.00% | – |
| Q2 2017 | $46,000 | +109.1% | 19,231 | +44.6% | 0.00% | – |
| Q1 2017 | $22,000 | -74.7% | 13,300 | -73.0% | 0.00% | – |
| Q3 2016 | $87,000 | -23.0% | 49,200 | -40.8% | 0.00% | – |
| Q2 2016 | $113,000 | +494.7% | 83,100 | +450.3% | 0.00% | – |
| Q1 2016 | $19,000 | -84.6% | 15,100 | -80.2% | 0.00% | – |
| Q4 2015 | $123,000 | -81.2% | 76,401 | -81.7% | 0.00% | – |
| Q3 2015 | $656,000 | -14.5% | 417,716 | -6.9% | 0.00% | – |
| Q2 2015 | $767,000 | -39.2% | 448,754 | -36.3% | 0.00% | – |
| Q1 2015 | $1,262,000 | +724.8% | 704,568 | +1862.0% | 0.00% | – |
| Q4 2014 | $153,000 | -22.3% | 35,910 | +25.6% | 0.00% | – |
| Q3 2014 | $197,000 | -63.7% | 28,600 | -41.3% | 0.00% | – |
| Q1 2014 | $542,000 | -45.1% | 48,720 | -60.5% | 0.00% | – |
| Q4 2013 | $988,000 | +19.2% | 123,307 | +68.6% | 0.00% | – |
| Q3 2013 | $829,000 | +852.9% | 73,139 | +499.5% | 0.00% | – |
| Q2 2013 | $87,000 | – | 12,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |